Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
Kura Oncology, Inc.
Company
CG Oncology, Inc.
Company
Aktis Oncology, Inc.
Company
Pyxis Oncology, Inc.
Company
CITIUS ONCOLOGY, INC.
Company
Coherus Oncology, Inc.
Company
Cardiff Oncology, Inc.
Company
Starling Oncology, Inc.
Company
CHAMPIONS ONCOLOGY, INC.
Company
ALX ONCOLOGY HOLDINGS INC
Company
Oura Inc.
Company
Onconetix, Inc.
Company
KURA SUSHI USA, INC.
Company
BridgeBio Oncology Therapeutics, Inc.
Company
KALTURA INC
Company
Primary record15
BlackRock, Inc. filed SCHEDULE 13G/A
0002012383-26-003813.txt : 20261027 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002012383 XXXXXXXX LIVE 8 Common Stock 09/30/2026 0001422143 Kura Oncology Inc 50127T109 4930 Directors Place, Suite 500 SAN DIEG
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-29.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-29.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-29.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-29.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-29.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-25.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-09-10.
Kura Oncology, Inc. filed 8-K
Item 8.01 Other Events. Subsidiary Financing Kura Oncology, Inc. (the Company ) formed a wholly owned subsidiary, Caspian Therapeutics, Inc. ( Caspian ), to focus on the development of next-generation menin inhibitors fo
Kura Oncology, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (c) Effective as of September 8, 2026, the Board of Directors (
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-08-24.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-08-24.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-08-21.
Kura Oncology, Inc. filed 4
SEC form 4 filed by Kura Oncology, Inc. (CIK 1422143) on 2026-08-17.
Kura Oncology, Inc. filed SCHEDULE 13G/A
, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that i